By Mill Chart
Last update: Aug 18, 2023
Our stock screener has flagged JOHNSON & JOHNSON (NYSE:JNJ) as a potential breakout candidate. This occurs when the stock shows signs of consolidation after a notable upward trend. While we can't predict the actual breakout, it's worth monitoring NYSE:JNJ for potential movement.
Every day, ChartMill assigns a Technical Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various technical indicators and properties.
Taking everything into account, JNJ scores 8 out of 10 in our technical rating. This is due to a decent performance in both the short and medium term time frames. Compared to the overall market, JNJ is only an average performer.
For an up to date full technical analysis you can check the technical report of JNJ
Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NYSE:JNJ this score is currently 8:
Besides having an excellent technical rating, JNJ also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 178.88. Right above this resistance zone may be a good entry point.
A breakout opportunity may arise when the stock surpasses the current consolidation zone and reaches new highs. Traders often wait for this breakout before considering buying the stock. To manage risk, a stop loss order could be placed below the consolidation zone to limit potential losses.
Please note that this article should not be construed as trading advice. The information provided is solely based on automated technical analysis and serves to highlight technical observations. It is important to conduct your own analysis and make trading decisions based on your own judgment and responsibility.
Every day, new breakout setups can be found on ChartMill in our Breakout screener.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
JOHNSON & JOHNSON
NYSE:JNJ (5/20/2024, 3:25:20 PM)
After market: 151.27 0 (0%)151.27
-3.37 (-2.18%)
Although the usual suspects grab the digital intelligence headlines, these underappreciated AI stocks deserve a closer look.
Johnson & Johnson (JNJ) inks deal to acquire Proteologix, Inc. for $850 million in cash. The transaction is expected to be closed in mid-2024.
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities.
Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside.
Discover three robotics and automation stocks that face significant challenges, including market saturation and competitive pressures.
Plus, Wegovy users keep the weight off, and Johnson & Johnson says goodbye to Tylenol
Is JOHNSON & JOHNSON (NYSE:JNJ) a Good Fit for Dividend Investing?
The market often doesn't know what to make of them at first, giving savvy investors first crack at these stock spinoffs to buy.
Johnson & Johnson to Buy Proteologix For $850 Million in Cash
These top consumer staples giants could be among the best ways for investors to retain defensive exposure in this current market.